Literature DB >> 30350627

A Monolayer of Primary Colonic Epithelium Generated on a Scaffold with a Gradient of Stiffness for Drug Transport Studies.

Dulan B Gunasekara1, Jennifer Speer, Yuli Wang, Daniel L Nguyen, Mark I Reed, Nicole M Smiddy, Joel S Parker2, John K Fallon, Philip C Smith, Christopher E Sims, Scott T Magness1, Nancy L Allbritton1.   

Abstract

Animal models are frequently used for in vitro physiologic and drug transport studies of the colon, but there exists significant pressure to improve assay throughput as well as to achieve tighter control of experimental variables than can be achieved with animals. Thus, development of a primary in vitro colonic epithelium cultured as high resistance with transport protein expression and functional behavior similar to that of a native colonic would be of enormous value for pharmaceutical research. A collagen scaffold, in which the degree of collagen cross-linking was present as a gradient, was developed to support the proliferation of primary colonic cells. The gradient of cross-linking created a gradient in stiffness across the scaffold, enabling the scaffold to resist deformation by cells. mRNA expression and quantitative proteomic mass spectrometry of cells growing on these surfaces as a monolayer suggested that the transporters present were similar to those in vivo. Confluent monolayers acted as a barrier to small molecules so that drug transport studies were readily performed. Transport function was evaluated using atenolol (a substrate for passive paracellular transport), propranolol (a substrate for passive transcellular transport), rhodamine 123 (Rh123, a substrate for P-glycoprotein), and riboflavin (a substrate for solute carrier transporters). Atenolol was poorly transported with an apparent permeability ( Papp) of <5 × 10-7 cm s-1, while propranolol demonstrated a Papp of 9.69 × 10-6 cm s-1. Rh123 was transported in a luminal direction ( Papp,efflux/ Papp,influx = 7) and was blocked by verapamil, a known inhibitor of P-glycoprotein. Riboflavin was transported in a basal direction, and saturation of the transporter was observed at high riboflavin concentrations as occurs in vivo. It is anticipated that this platform of primary colonic epithelium will find utility in drug development and physiological studies, since the tissue possesses high integrity and active transporters and metabolism similar to that in vivo.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30350627      PMCID: PMC6339567          DOI: 10.1021/acs.analchem.8b02845

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  36 in total

Review 1.  Intestinal drug transporters: in vivo function and clinical importance.

Authors:  Jeevan R Kunta; Patrick J Sinko
Journal:  Curr Drug Metab       Date:  2004-02       Impact factor: 3.731

Review 2.  A guide to Ussing chamber studies of mouse intestine.

Authors:  Lane L Clarke
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-02       Impact factor: 4.052

3.  Targeted quantitative proteomics for the analysis of 14 UGT1As and -2Bs in human liver using NanoUPLC-MS/MS with selected reaction monitoring.

Authors:  John K Fallon; Hendrik Neubert; Ruth Hyland; Theunis C Goosen; Philip C Smith
Journal:  J Proteome Res       Date:  2013-09-26       Impact factor: 4.466

4.  Sox9 expression marks a subset of CD24-expressing small intestine epithelial stem cells that form organoids in vitro.

Authors:  Adam D Gracz; Sendhilnathan Ramalingam; Scott T Magness
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-02-25       Impact factor: 4.052

5.  Real-time analysis of P-glycoprotein-mediated drug transport across primary intestinal epithelium three-dimensionally cultured in vitro.

Authors:  Tomohiro Mizutani; Tetsuya Nakamura; Ryo Morikawa; Masayoshi Fukuda; Wakana Mochizuki; Yuhki Yamauchi; Kengo Nozaki; Shiro Yui; Yasuhiro Nemoto; Takashi Nagaishi; Ryuichi Okamoto; Kiichiro Tsuchiya; Mamoru Watanabe
Journal:  Biochem Biophys Res Commun       Date:  2012-02-07       Impact factor: 3.575

Review 6.  Emerging transporters of clinical importance: an update from the International Transporter Consortium.

Authors:  K M Hillgren; D Keppler; A A Zur; K M Giacomini; B Stieger; C E Cass; L Zhang
Journal:  Clin Pharmacol Ther       Date:  2013-04-08       Impact factor: 6.875

Review 7.  The Caco-2 cell monolayer: usefulness and limitations.

Authors:  Huadong Sun; Edwin Cy Chow; Shanjun Liu; Yimin Du; K Sandy Pang
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-04       Impact factor: 4.481

8.  A functional CFTR assay using primary cystic fibrosis intestinal organoids.

Authors:  Johanna F Dekkers; Caroline L Wiegerinck; Hugo R de Jonge; Inez Bronsveld; Hettie M Janssens; Karin M de Winter-de Groot; Arianne M Brandsma; Nienke W M de Jong; Marcel J C Bijvelds; Bob J Scholte; Edward E S Nieuwenhuis; Stieneke van den Brink; Hans Clevers; Cornelis K van der Ent; Sabine Middendorp; Jeffrey M Beekman
Journal:  Nat Med       Date:  2013-06-02       Impact factor: 53.440

9.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.

Authors:  Michael I Love; Wolfgang Huber; Simon Anders
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

10.  Self-renewing Monolayer of Primary Colonic or Rectal Epithelial Cells.

Authors:  Yuli Wang; Matthew DiSalvo; Dulan B Gunasekara; Johanna Dutton; Angela Proctor; Michael S Lebhar; Ian A Williamson; Jennifer Speer; Riley L Howard; Nicole M Smiddy; Scott J Bultman; Christopher E Sims; Scott T Magness; Nancy L Allbritton
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-03-06
View more
  10 in total

1.  An in vitro intestinal platform with a self-sustaining oxygen gradient to study the human gut/microbiome interface.

Authors:  Raehyun Kim; Peter J Attayek; Yuli Wang; Kathleen L Furtado; Rita Tamayo; Christopher E Sims; Nancy L Allbritton
Journal:  Biofabrication       Date:  2019-11-06       Impact factor: 9.954

2.  Stem/Proliferative and Differentiated Cells within Primary Murine Colonic Epithelium Display Distinct Intracellular Free Ca2+ Signal Codes.

Authors:  Sebastian Mestril; Raehyun Kim; Samuel S Hinman; Shawn M Gomez; Nancy L Allbritton
Journal:  Adv Healthc Mater       Date:  2021-09-12       Impact factor: 9.933

Review 3.  Established and novel human translational models to advance cystic fibrosis research, drug discovery, and optimize CFTR-targeting therapeutics.

Authors:  Deborah M Cholon; Martina Gentzsch
Journal:  Curr Opin Pharmacol       Date:  2022-04-21       Impact factor: 4.768

4.  Hyperglycemia minimally alters primary self-renewing human colonic epithelial cells while TNFα-promotes severe intestinal epithelial dysfunction.

Authors:  Johanna S Dutton; Samuel S Hinman; Raehyun Kim; Peter J Attayek; Mallory Maurer; Christopher S Sims; Nancy L Allbritton
Journal:  Integr Biol (Camb)       Date:  2021-06-15       Impact factor: 2.192

5.  In vitro generation of self-renewing human intestinal epithelia over planar and shaped collagen hydrogels.

Authors:  Samuel S Hinman; Yuli Wang; Raehyun Kim; Nancy L Allbritton
Journal:  Nat Protoc       Date:  2020-12-09       Impact factor: 13.491

6.  Molecular transport through primary human small intestinal monolayers by culture on a collagen scaffold with a gradient of chemical cross-linking.

Authors:  Jennifer E Speer; Dulan B Gunasekara; Yuli Wang; John K Fallon; Peter J Attayek; Philip C Smith; Christopher E Sims; Nancy L Allbritton
Journal:  J Biol Eng       Date:  2019-04-27       Impact factor: 4.355

7.  Long-Term Culture Captures Injury-Repair Cycles of Colonic Stem Cells.

Authors:  Yi Wang; I-Ling Chiang; Takahiro E Ohara; Satoru Fujii; Jiye Cheng; Brian D Muegge; Aaron Ver Heul; Nathan D Han; Qiuhe Lu; Shanshan Xiong; Feidi Chen; Chin-Wen Lai; Hana Janova; Renee Wu; Charles E Whitehurst; Kelli L VanDussen; Ta-Chiang Liu; Jeffrey I Gordon; L David Sibley; Thaddeus S Stappenbeck
Journal:  Cell       Date:  2019-11-07       Impact factor: 41.582

8.  Evaluation of human primary intestinal monolayers for drug metabolizing capabilities.

Authors:  Jennifer E Speer; Yuli Wang; John K Fallon; Philip C Smith; Nancy L Allbritton
Journal:  J Biol Eng       Date:  2019-11-04       Impact factor: 4.355

Review 9.  Microfluidic lumen-based systems for advancing tubular organ modeling.

Authors:  María Virumbrales-Muñoz; José M Ayuso; Max M Gong; Mouhita Humayun; Megan K Livingston; Karina M Lugo-Cintrón; Patrick McMinn; Yasmín R Álvarez-García; David J Beebe
Journal:  Chem Soc Rev       Date:  2020-09-01       Impact factor: 60.615

10.  Decreased Colonic Activin Receptor-Like Kinase 1 Disrupts Epithelial Barrier Integrity in Patients With Crohn's Disease.

Authors:  Takahiko Toyonaga; Erin C Steinbach; Benjamin P Keith; Jasmine B Barrow; Matthew R Schaner; Elisabeth A Wolber; Caroline Beasley; Jennifer Huling; Yuli Wang; Nancy L Allbritton; Nicole Chaumont; Timothy S Sadiq; Mark J Koruda; Animesh Jain; Millie D Long; Edward L Barnes; Hans H Herfarth; Kim L Isaacs; Jonathan J Hansen; Michael T Shanahan; Reza Rahbar; Terrence S Furey; Praveen Sethupathy; Shehzad Z Sheikh
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2020-06-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.